Loading ESPR...
Esperion Therapeutics Inc.ESPRAs of 14 July 2026
−37
PositiveNegative
Equilibrium
Asymmetry
Is Esperion Therapeutics Inc. a good buy right now?
Whether Esperion Therapeutics Inc. (ESPR) looks like a good buy comes down to three things: how it is valued, how the market feels about it, and how strong the underlying business is. Each is measured against Esperion Therapeutics Inc.'s own five-year history, so you see genuine dislocation rather than noise. Information, not advice.
Esperion Therapeutics Inc.ESPRLast 5 years
V—E—F—A—
——
ESPR priceasymmetryquant.com